Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.
The Reimbursement Liaison will serve as an expert in reimbursement policies to ensure patients have access to Glaukos' sight saving technologies. They will work with physician practices to educate HCPs and their staff on clinical documentation, securing treatment approvals, patient tracking, claim submission, and more.
Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.